日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structural ontogeny of protein-protein interactions

蛋白质-蛋白质相互作用的结构发育

Yang, Aerin; Jiang, Hanlun; Jude, Kevin M; Akpinaroglu, Deniz; Allenspach, Stephan; Li, Alex Jie; Bowden, James; Perez, Carla Patricia; Liu, Liu; Huang, Po-Ssu; Kortemme, Tanja; Listgarten, Jennifer; Garcia, K Christopher

Targeted delivery of genome editors in vivo

体内靶向递送基因组编辑工具

Ngo, Wayne; Wu, Jamie L Y; Wasko, Kevin M; Doudna, Jennifer A

IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy

IL-9 作为一种天然正交细胞因子,具有最佳的 JAK/STAT 信号通路活性,可用于工程化 T 细胞治疗。

Hua Jiang,Sam Limsuwannarot,Kayla R Kulhanek,Aastha Pal,Ossama Labiad,Lea W Rysavy,Ada Wong,Leon Su,Sarah Cavender,Johnathon Soro,Stefano Testa,Heather Ogana,Deepa Waghray,Pingdong Tao,Kevin M Jude,Christopher S Seet,Gay M Crooks,Everett J Moding,K Christopher Garcia,Anusha Kalbasi

Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugs

溶质载体转运蛋白在化疗药物生物分布和毒性中的作用

Boeckman, Mike; Drabison, Thomas; Germakovski, Arthur; Warmuth, Allison; Ahmed, Bagdad; Chowdhury, Anika T; Hu, Shuiying; Sprowl, Jason A; Sparreboom, Alex; Huang, Kevin M

KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment

KRASG12R突变型胰腺癌具有ERK/MAPK转录活性受限和独特的肿瘤微环境。

Burge, Rachel A; Le Roux, Ozgun; Popow, Olesja; Spadafora, Victoria K; Rajesh, Christabelle; Adair, Sara J; Bialousow, Lucas; Murphy, Cailey; Saberi, Samaneh; Vaena, Silvia G; Taquey, Margaret C; Allen, Sarah; Han, Lu; Helke, Kristi L; Sharma, Sudarshana; Ostrowski, Michael C; Guttridge, Denis C; Dincman, Toros A; Bauer, Todd W; Kashatus, David F; McFall, Thomas; Haigis, Kevin M; Hollingsworth, Michael A; Counter, Christopher M; Der, Channing J; Hobbs, G Aaron

Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains.

确定能够逆转具有朊病毒样结构域的 RNA 结合蛋白的有害相变的 RNA 寡核苷酸。

Guo Lin, Mann Jacob R, Mauna Jocelyn C, Copley Katie E, Wang Hejia, Rubien Jack D, Bergmann Cristian A, Carey Jenny L, Merjane Jessica, Ngo Marilyn, Xu Jiazhen, Odeh Hana M, Lin JiaBei, Lee Bo Lim, Ganser Laura, Robinson Emma, Kim Kevin M, Murthy Anastasia C, Paul Tapas, Portz Bede, Gleixner Amanda M, Diaz Zamia, Smirnov Ashleigh, Padilla George, Lavorando Ellen, Espy Carolann, Shang Yulei, Huang Eric J, Chesi Alessandra, Fawzi Nicolas L, Myong Sua, Donnelly Christopher J, Shorter James

Assembling unregulated DNA segments bypasses synthesis screening: regulate fragments as select agents

组装不受调控的DNA片段绕过了合成筛选:将调控片段作为选择性试剂。

Edison, Rey; Toner, Shay; Esvelt, Kevin M

Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension

Acoramidis治疗野生型和变异型转甲状腺素蛋白淀粉样变性心肌病的疗效:来自ATTRibute-CM及其开放标签扩展研究的结果

Alexander, Kevin M; Davis, Margot K; Akinboboye, Olakunle; Berk, John; Bhatt, Kunal; Cappelli, Francesco; Cuddy, Sarah A M; Fontana, Marianna; Garcia-Pavia, Pablo; Gillmore, Julian D; Griffin, Jan M; Grodin, Justin L; Judge, Daniel P; Khouri, Michel G; Lam, Kaitlyn; Masri, Ahmad; Maurer, Mathew S; Obici, Laura; Ruberg, Frederick L; Sarswat, Nitasha; Shah, Keyur; Soman, Prem; Stern, Lily; Wright, Richard; Xiong, Kuangnan; Cao, Xiaofan; Lystig, Ted; Tamby, Jean-François; Castaño, Adam; Katz, Leonid; Sinha, Uma; Fox, Jonathan C; Solomon, Scott D; Grogan, Martha

Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial

Acoramidis治疗转甲状腺素蛋白淀粉样变性心肌病的长期疗效:ATTRibute-CM随机临床试验的开放标签扩展研究

Soman, Prem; Cuddy, Sarah A M; Gillmore, Julian D; Sarswat, Nitasha; Judge, Daniel P; Cappelli, Francesco; Stern, Lily K; Wright, Richard; Akinboboye, Olakunle; Obici, Laura; Bhatt, Kunal; Xiong, Kuangnan; Castaño, Adam; Chen, Chris; Falvey, Heather; Pecoraro, Maria Lucia; Tamby, Jean-François; Sinha, Uma; Fox, Jonathan C; Shah, Keyur; Grodin, Justin L; Ambardekar, Amrut V; Alexander, Kevin M; Khouri, Michel G; Cheng, Richard K

A disrupted compartment boundary underlies abnormal cardiac patterning and congenital heart defects.

心腔边界紊乱是心脏异常发育和先天性心脏缺陷的根本原因。

Kathiriya Irfan S, Dominguez Martin H, Rao Kavitha S, Muncie-Vasic Jonathon M, Devine W Patrick, Hu Kevin M, Hota Swetansu K, Garay Bayardo I, Quintero Diego, Goyal Piyush, Matthews Megan N, Thomas Reuben, Sukonnik Tatyana, Miguel-Perez Dario, Winchester Sarah, Brower Emily F, Forjaz André, Wu Pei-Hsun, Wirtz Denis, Kiemen Ashley L, Bruneau Benoit G